APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioconjugates Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bioconjugates Service Market Outlook and Growth Opportunities 2026

22 January 2026217 pages

Choose your research edition.

Industry ResearchBioconjugates Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioconjugates Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Bioconjugates Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioconjugates Service Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioconjugates Service Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Bioconjugates Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bioconjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bioconjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioconjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bioconjugates Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bioconjugates Service market include CellMosaic, AAT Bioquest, Creative Biolabs, Lonza, Bio-Synthesis, NJ Bio, Macrocyclics, KareBay and MuseChem, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bioconjugates Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bioconjugates Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bioconjugates Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bioconjugates Service market.

Bioconjugates Service Segment by Company

CellMosaic

AAT Bioquest

Creative Biolabs

Lonza

Bio-Synthesis

NJ Bio

Macrocyclics

KareBay

MuseChem

CheMatech

Recipharm

Nanocs

Vector Laboratories

Cell Signaling Technology

Thermo Fisher

WuXi Biologics

Celares

GTP Bioways

Antibody Solutions

BOC Sciences

Novasep

Bioconjugates Service Segment by Type

Covalent Conjugation Service

Non-Covalent Conjugation Service

Site-specific Conjugation Service

Bioconjugates Service Segment by Application

Therapeutic Drug Development

Diagnostic Probe Manufacturing

Basic Biological Research

Other

Bioconjugates Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bioconjugates Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bioconjugates Service key companies, revenue, market share, and recent developments.

3. To split the Bioconjugates Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bioconjugates Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bioconjugates Service significant trends, drivers, influence factors in global and regions.

6. To analyze Bioconjugates Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugates Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioconjugates Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugates Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bioconjugates Service industry.

Chapter 3: Detailed analysis of Bioconjugates Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bioconjugates Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bioconjugates Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bioconjugates Service Industry Trends Table 2. Bioconjugates Service Industry Drivers Table 3. Bioconjugates Service Industry Opportunities and Challenges Table 4. Bioconjugates Service Industry Restraints Table 5. Global Bioconjugates Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bioconjugates Service Revenue Share by Company (2021-2026) Table 7. Global Bioconjugates Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bioconjugates Service Key Company Manufacturing Base & Headquarters Table 9. Global Bioconjugates Service Company, Product Type & Application Table 10. Global Bioconjugates Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bioconjugates Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Covalent Conjugation Service Table 15. Significant Companies of Non-Covalent Conjugation Service Table 16. Significant Companies of Site-specific Conjugation Service Table 17. Global Bioconjugates Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Bioconjugates Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Bioconjugates Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Bioconjugates Service Sales Value Share by Type (2021-2026) Table 21. Global Bioconjugates Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Therapeutic Drug Development Table 23. Significant Companies of Diagnostic Probe Manufacturing Table 24. Significant Companies of Basic Biological Research Table 25. Significant Companies of Other Table 26. Global Bioconjugates Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Bioconjugates Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Bioconjugates Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Bioconjugates Service Sales Value Share by Application (2021-2026) Table 30. Global Bioconjugates Service Sales Value Share by Application (2027-2032) Table 31. Global Bioconjugates Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Bioconjugates Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Bioconjugates Service Sales Value Share by Region (2021-2026) Table 34. Global Bioconjugates Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Bioconjugates Service Sales Value Share by Region (2027-2032) Table 36. Global Bioconjugates Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Bioconjugates Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Bioconjugates Service Sales Value Market Share by Country (2021-2026) Table 39. Global Bioconjugates Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Bioconjugates Service Sales Value Market Share by Country (2027-2032) Table 41. CellMosaic Company Information Table 42. CellMosaic Business Overview Table 43. CellMosaic Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. CellMosaic Bioconjugates Service Product Portfolio Table 45. CellMosaic Recent Development Table 46. AAT Bioquest Company Information Table 47. AAT Bioquest Business Overview Table 48. AAT Bioquest Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. AAT Bioquest Bioconjugates Service Product Portfolio Table 50. AAT Bioquest Recent Development Table 51. Creative Biolabs Company Information Table 52. Creative Biolabs Business Overview Table 53. Creative Biolabs Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Creative Biolabs Bioconjugates Service Product Portfolio Table 55. Creative Biolabs Recent Development Table 56. Lonza Company Information Table 57. Lonza Business Overview Table 58. Lonza Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Lonza Bioconjugates Service Product Portfolio Table 60. Lonza Recent Development Table 61. Bio-Synthesis Company Information Table 62. Bio-Synthesis Business Overview Table 63. Bio-Synthesis Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Bio-Synthesis Bioconjugates Service Product Portfolio Table 65. Bio-Synthesis Recent Development Table 66. NJ Bio Company Information Table 67. NJ Bio Business Overview Table 68. NJ Bio Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. NJ Bio Bioconjugates Service Product Portfolio Table 70. NJ Bio Recent Development Table 71. Macrocyclics Company Information Table 72. Macrocyclics Business Overview Table 73. Macrocyclics Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Macrocyclics Bioconjugates Service Product Portfolio Table 75. Macrocyclics Recent Development Table 76. KareBay Company Information Table 77. KareBay Business Overview Table 78. KareBay Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. KareBay Bioconjugates Service Product Portfolio Table 80. KareBay Recent Development Table 81. MuseChem Company Information Table 82. MuseChem Business Overview Table 83. MuseChem Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. MuseChem Bioconjugates Service Product Portfolio Table 85. MuseChem Recent Development Table 86. CheMatech Company Information Table 87. CheMatech Business Overview Table 88. CheMatech Bioconjugates Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CheMatech Bioconjugates Service Product Portfolio Table 90. CheMatech Recent Development Table 91. Recipharm Company Information Table 92. Recipharm Business Overview Table 93. Recipharm Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Recipharm Bioconjugates Service Product Portfolio Table 95. Recipharm Recent Development Table 96. Nanocs Company Information Table 97. Nanocs Business Overview Table 98. Nanocs Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Nanocs Bioconjugates Service Product Portfolio Table 100. Nanocs Recent Development Table 101. Vector Laboratories Company Information Table 102. Vector Laboratories Business Overview Table 103. Vector Laboratories Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Vector Laboratories Bioconjugates Service Product Portfolio Table 105. Vector Laboratories Recent Development Table 106. Cell Signaling Technology Company Information Table 107. Cell Signaling Technology Business Overview Table 108. Cell Signaling Technology Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Cell Signaling Technology Bioconjugates Service Product Portfolio Table 110. Cell Signaling Technology Recent Development Table 111. Thermo Fisher Company Information Table 112. Thermo Fisher Business Overview Table 113. Thermo Fisher Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Thermo Fisher Bioconjugates Service Product Portfolio Table 115. Thermo Fisher Recent Development Table 116. WuXi Biologics Company Information Table 117. WuXi Biologics Business Overview Table 118. WuXi Biologics Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. WuXi Biologics Bioconjugates Service Product Portfolio Table 120. WuXi Biologics Recent Development Table 121. Celares Company Information Table 122. Celares Business Overview Table 123. Celares Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Celares Bioconjugates Service Product Portfolio Table 125. Celares Recent Development Table 126. GTP Bioways Company Information Table 127. GTP Bioways Business Overview Table 128. GTP Bioways Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. GTP Bioways Bioconjugates Service Product Portfolio Table 130. GTP Bioways Recent Development Table 131. Antibody Solutions Company Information Table 132. Antibody Solutions Business Overview Table 133. Antibody Solutions Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Antibody Solutions Bioconjugates Service Product Portfolio Table 135. Antibody Solutions Recent Development Table 136. BOC Sciences Company Information Table 137. BOC Sciences Business Overview Table 138. BOC Sciences Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. BOC Sciences Bioconjugates Service Product Portfolio Table 140. BOC Sciences Recent Development Table 141. Novasep Company Information Table 142. Novasep Business Overview Table 143. Novasep Bioconjugates Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Novasep Bioconjugates Service Product Portfolio Table 145. Novasep Recent Development Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Bioconjugates Service Product Image Figure 2. Global Bioconjugates Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioconjugates Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioconjugates Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Covalent Conjugation Service Image Figure 8. Non-Covalent Conjugation Service Image Figure 9. Site-specific Conjugation Service Image Figure 10. Global Bioconjugates Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Bioconjugates Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Bioconjugates Service Sales Value Share by Type (2021-2032) Figure 13. Therapeutic Drug Development Image Figure 14. Diagnostic Probe Manufacturing Image Figure 15. Basic Biological Research Image Figure 16. Other Image Figure 17. Global Bioconjugates Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Bioconjugates Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Bioconjugates Service Sales Value Share by Application (2021-2032) Figure 20. Global Bioconjugates Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Bioconjugates Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Bioconjugates Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Bioconjugates Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Bioconjugates Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Bioconjugates Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Bioconjugates Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Bioconjugates Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Bioconjugates Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Bioconjugates Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Bioconjugates Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Bioconjugates Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Bioconjugates Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Bioconjugates Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Bioconjugates Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Covalent Conjugation Service
  • Non-Covalent Conjugation Service
  • Site-specific Conjugation Service
Applications
  • Therapeutic Drug Development
  • Diagnostic Probe Manufacturing
  • Basic Biological Research
  • Other
Companies covered
  • CellMosaic
  • AAT Bioquest
  • Creative Biolabs
  • Lonza
  • Bio-Synthesis
  • NJ Bio
  • Macrocyclics
  • KareBay
  • MuseChem
  • CheMatech
  • Recipharm
  • Nanocs
  • Vector Laboratories
  • Cell Signaling Technology
  • Thermo Fisher
  • WuXi Biologics
  • Celares
  • GTP Bioways
  • Antibody Solutions
  • BOC Sciences
  • Novasep

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bioconjugates Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bioconjugates Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bioconjugates Service Market Dynamics
  1. 2.1 Bioconjugates Service Industry Trends
  2. 2.2 Bioconjugates Service Industry Drivers
  3. 2.3 Bioconjugates Service Industry Opportunities and Challenges
  4. 2.4 Bioconjugates Service Industry Restraints
3 Bioconjugates Service Market by Company
  1. 3.1 Global Bioconjugates Service Company Revenue Ranking in 2025
  2. 3.2 Global Bioconjugates Service Revenue by Company (2021-2026)
  3. 3.3 Global Bioconjugates Service Company Ranking (2024-2026)
  4. 3.4 Global Bioconjugates Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Bioconjugates Service Company Product Type and Application
  6. 3.6 Global Bioconjugates Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bioconjugates Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bioconjugates Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bioconjugates Service Market by Type
  1. 4.1 Bioconjugates Service Type Introduction
  2. 4.1.1 Covalent Conjugation Service
  3. 4.1.2 Non-Covalent Conjugation Service
  4. 4.1.3 Site-specific Conjugation Service
  5. 4.2 Global Bioconjugates Service Sales Value by Type
  6. 4.2.1 Global Bioconjugates Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bioconjugates Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Bioconjugates Service Sales Value Share by Type (2021-2032)
5 Bioconjugates Service Market by Application
  1. 5.1 Bioconjugates Service Application Introduction
  2. 5.1.1 Therapeutic Drug Development
  3. 5.1.2 Diagnostic Probe Manufacturing
  4. 5.1.3 Basic Biological Research
  5. 5.1.4 Other
  6. 5.2 Global Bioconjugates Service Sales Value by Application
  7. 5.2.1 Global Bioconjugates Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bioconjugates Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Bioconjugates Service Sales Value Share by Application (2021-2032)
6 Bioconjugates Service Regional Value Analysis
  1. 6.1 Global Bioconjugates Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bioconjugates Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bioconjugates Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bioconjugates Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bioconjugates Service Sales Value (2021-2032)
  7. 6.3.2 North America Bioconjugates Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bioconjugates Service Sales Value (2021-2032)
  10. 6.4.2 Europe Bioconjugates Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bioconjugates Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bioconjugates Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bioconjugates Service Sales Value (2021-2032)
  16. 6.6.2 South America Bioconjugates Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bioconjugates Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bioconjugates Service Sales Value Share by Country, 2025 VS 2032
7 Bioconjugates Service Country-level Value Analysis
  1. 7.1 Global Bioconjugates Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bioconjugates Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bioconjugates Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bioconjugates Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bioconjugates Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bioconjugates Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bioconjugates Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bioconjugates Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bioconjugates Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bioconjugates Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bioconjugates Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bioconjugates Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bioconjugates Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bioconjugates Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bioconjugates Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bioconjugates Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bioconjugates Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bioconjugates Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bioconjugates Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bioconjugates Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bioconjugates Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bioconjugates Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bioconjugates Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bioconjugates Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bioconjugates Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bioconjugates Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bioconjugates Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bioconjugates Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bioconjugates Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bioconjugates Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bioconjugates Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bioconjugates Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bioconjugates Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bioconjugates Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CellMosaic
  2. 8.1.1 CellMosaic Company Information
  3. 8.1.2 CellMosaic Business Overview
  4. 8.1.3 CellMosaic Bioconjugates Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CellMosaic Bioconjugates Service Product Portfolio
  6. 8.1.5 CellMosaic Recent Developments
  7. 8.2 AAT Bioquest
  8. 8.2.1 AAT Bioquest Company Information
  9. 8.2.2 AAT Bioquest Business Overview
  10. 8.2.3 AAT Bioquest Bioconjugates Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AAT Bioquest Bioconjugates Service Product Portfolio
  12. 8.2.5 AAT Bioquest Recent Developments
  13. 8.3 Creative Biolabs
  14. 8.3.1 Creative Biolabs Company Information
  15. 8.3.2 Creative Biolabs Business Overview
  16. 8.3.3 Creative Biolabs Bioconjugates Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Creative Biolabs Bioconjugates Service Product Portfolio
  18. 8.3.5 Creative Biolabs Recent Developments
  19. 8.4 Lonza
  20. 8.4.1 Lonza Company Information
  21. 8.4.2 Lonza Business Overview
  22. 8.4.3 Lonza Bioconjugates Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lonza Bioconjugates Service Product Portfolio
  24. 8.4.5 Lonza Recent Developments
  25. 8.5 Bio-Synthesis
  26. 8.5.1 Bio-Synthesis Company Information
  27. 8.5.2 Bio-Synthesis Business Overview
  28. 8.5.3 Bio-Synthesis Bioconjugates Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Synthesis Bioconjugates Service Product Portfolio
  30. 8.5.5 Bio-Synthesis Recent Developments
  31. 8.6 NJ Bio
  32. 8.6.1 NJ Bio Company Information
  33. 8.6.2 NJ Bio Business Overview
  34. 8.6.3 NJ Bio Bioconjugates Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NJ Bio Bioconjugates Service Product Portfolio
  36. 8.6.5 NJ Bio Recent Developments
  37. 8.7 Macrocyclics
  38. 8.7.1 Macrocyclics Company Information
  39. 8.7.2 Macrocyclics Business Overview
  40. 8.7.3 Macrocyclics Bioconjugates Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Macrocyclics Bioconjugates Service Product Portfolio
  42. 8.7.5 Macrocyclics Recent Developments
  43. 8.8 KareBay
  44. 8.8.1 KareBay Company Information
  45. 8.8.2 KareBay Business Overview
  46. 8.8.3 KareBay Bioconjugates Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 KareBay Bioconjugates Service Product Portfolio
  48. 8.8.5 KareBay Recent Developments
  49. 8.9 MuseChem
  50. 8.9.1 MuseChem Company Information
  51. 8.9.2 MuseChem Business Overview
  52. 8.9.3 MuseChem Bioconjugates Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MuseChem Bioconjugates Service Product Portfolio
  54. 8.9.5 MuseChem Recent Developments
  55. 8.10 CheMatech
  56. 8.10.1 CheMatech Company Information
  57. 8.10.2 CheMatech Business Overview
  58. 8.10.3 CheMatech Bioconjugates Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CheMatech Bioconjugates Service Product Portfolio
  60. 8.10.5 CheMatech Recent Developments
  61. 8.11 Recipharm
  62. 8.11.1 Recipharm Company Information
  63. 8.11.2 Recipharm Business Overview
  64. 8.11.3 Recipharm Bioconjugates Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Recipharm Bioconjugates Service Product Portfolio
  66. 8.11.5 Recipharm Recent Developments
  67. 8.12 Nanocs
  68. 8.12.1 Nanocs Company Information
  69. 8.12.2 Nanocs Business Overview
  70. 8.12.3 Nanocs Bioconjugates Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nanocs Bioconjugates Service Product Portfolio
  72. 8.12.5 Nanocs Recent Developments
  73. 8.13 Vector Laboratories
  74. 8.13.1 Vector Laboratories Company Information
  75. 8.13.2 Vector Laboratories Business Overview
  76. 8.13.3 Vector Laboratories Bioconjugates Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vector Laboratories Bioconjugates Service Product Portfolio
  78. 8.13.5 Vector Laboratories Recent Developments
  79. 8.14 Cell Signaling Technology
  80. 8.14.1 Cell Signaling Technology Company Information
  81. 8.14.2 Cell Signaling Technology Business Overview
  82. 8.14.3 Cell Signaling Technology Bioconjugates Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cell Signaling Technology Bioconjugates Service Product Portfolio
  84. 8.14.5 Cell Signaling Technology Recent Developments
  85. 8.15 Thermo Fisher
  86. 8.15.1 Thermo Fisher Company Information
  87. 8.15.2 Thermo Fisher Business Overview
  88. 8.15.3 Thermo Fisher Bioconjugates Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Thermo Fisher Bioconjugates Service Product Portfolio
  90. 8.15.5 Thermo Fisher Recent Developments
  91. 8.16 WuXi Biologics
  92. 8.16.1 WuXi Biologics Company Information
  93. 8.16.2 WuXi Biologics Business Overview
  94. 8.16.3 WuXi Biologics Bioconjugates Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 WuXi Biologics Bioconjugates Service Product Portfolio
  96. 8.16.5 WuXi Biologics Recent Developments
  97. 8.17 Celares
  98. 8.17.1 Celares Company Information
  99. 8.17.2 Celares Business Overview
  100. 8.17.3 Celares Bioconjugates Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Celares Bioconjugates Service Product Portfolio
  102. 8.17.5 Celares Recent Developments
  103. 8.18 GTP Bioways
  104. 8.18.1 GTP Bioways Company Information
  105. 8.18.2 GTP Bioways Business Overview
  106. 8.18.3 GTP Bioways Bioconjugates Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 GTP Bioways Bioconjugates Service Product Portfolio
  108. 8.18.5 GTP Bioways Recent Developments
  109. 8.19 Antibody Solutions
  110. 8.19.1 Antibody Solutions Company Information
  111. 8.19.2 Antibody Solutions Business Overview
  112. 8.19.3 Antibody Solutions Bioconjugates Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Antibody Solutions Bioconjugates Service Product Portfolio
  114. 8.19.5 Antibody Solutions Recent Developments
  115. 8.20 BOC Sciences
  116. 8.20.1 BOC Sciences Company Information
  117. 8.20.2 BOC Sciences Business Overview
  118. 8.20.3 BOC Sciences Bioconjugates Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 BOC Sciences Bioconjugates Service Product Portfolio
  120. 8.20.5 BOC Sciences Recent Developments
  121. 8.21 Novasep
  122. 8.21.1 Novasep Company Information
  123. 8.21.2 Novasep Business Overview
  124. 8.21.3 Novasep Bioconjugates Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Novasep Bioconjugates Service Product Portfolio
  126. 8.21.5 Novasep Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst